Mark G. Foletta, Director at DEXCOM INC (DXCM), sold 4,000 shares at $80.00 ($331K) on 2026-07-31, disclosed to the SEC on 2026-08-04.
Scheduled sale ($331k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $80.00 | 2,000 | $160K | 48.4% |
| 2 | $85.32 | 2,000 | $171K | 51.6% |
| Total | $82.66 avg | 4,000 | $331K | 100% |
| Filing → |
| DXCM | SELL | 2025-08-18 | $430K | — | Filing → |
| DXCM | SELL | 2025-07-17 | $468K | — | Filing → |
| DXCM | SELL | 2025-06-18 | $457K | — | Filing → |